Extraintestinal manifestation of inflammatory bowel disease and associated factors in pediatric patients

Parisa Rahmani1, Ghazaleh Rasti1, Mojtaba Gorgi2

  • 1Pediatric Gastroenterology and Hepatology Research Center, Children's Medical Center, Pediatric Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.

Insights

Oral plaque severity correlates with disease severity in pediatric inflammatory bowel disease (IBD). Standardizing scoring systems is recommended for better assessment of extraintestinal manifestations in Crohn's disease and ulcerative colitis.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Manifestations of IBD

Background:

  • Extraintestinal manifestations (EIMs) are common in pediatric inflammatory bowel disease (IBD), affecting various organ systems.
  • Understanding factors influencing IBD severity and EIMs is crucial for effective patient management.

Purpose of the Study:

  • To investigate factors determining disease severity in pediatric IBD.
  • To evaluate the prevalence and associations of extraintestinal manifestations (EIMs) in pediatric Crohn's disease (CD) and ulcerative colitis (UC).
  • To assess the utility of disease activity scoring systems in relation to EIMs.

Main Methods:

  • A cross-sectional study involving 73 pediatric patients with IBD (CD and UC).
  • Data collected included medical history, gastrointestinal complications, and incidence of EIMs.
  • Disease activity was assessed using the Pediatric Crohn's Disease Activity Index (PCDAI) for CD and the Pediatric Ulcerative Colitis Activity Index (PUCAI) for UC.

Main Results:

  • The study included 54.80% with UC and 45.20% with CD.
  • Prevalent symptoms included weight loss, diarrhea, and abdominal pain in both CD and UC.
  • The most common EIMs were arthritis (21.21% in CD, 12.5% in UC), oral plaque (15.15% in CD), and erythema nodosum (6.06% in CD).

Conclusions:

  • Oral plaque severity showed a positive association with overall disease severity in pediatric IBD.
  • No significant associations were found between other assessed parameters and disease severity or EIMs.
  • Standardization of scoring systems is recommended for accurately determining EIMs in IBD.
Abstract

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
390
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
434
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
554
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
443
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
220
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
415